Xtant Medical Holdings (XTNT) Gains from Investment Securities (2014 - 2025)
Xtant Medical Holdings (XTNT) reported Gains from Investment Securities of $70000.0 for Q4 2025, up 233.33% year-over-year from $21000.0 in Q4 2024, and down 57.56% quarter-over-quarter from $164931.0 in Q3 2025.
Xtant Medical Holdings (XTNT) Gains from Investment Securities (2014 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 12 years of Gains from Investment Securities data on file, last reported at $70000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $70000.0, up 233.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.8 million (changed 0.49% YoY), and the FY2025 annual result was $1.7 million, down 56.71% from the prior year.
- Gains from Investment Securities retreated to $70000.0 in Q4 2025 per XTNT's latest filing, from $164931.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $11.6 million in Q4 2023 and troughed at $8000.0 in Q4 2021.
- A 5-year average of $1.8 million and a median of $164931.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 77553.33% in 2023, then tumbled 99.82% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $8000.0 in 2021, then jumped by 87.5% to $15000.0 in 2022, then soared by 77553.33% to $11.6 million in 2023, then plunged by 99.82% to $21000.0 in 2024, then surged by 233.33% to $70000.0 in 2025.
- Business Quant data shows XTNT's Gains from Investment Securities at $70000.0 in Q4 2025, $164931.0 in Q3 2025, and $164931.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 70,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 164,931.00 |
| Sep 30, 2025 | 164,931.00 |
| Jun 30, 2025 | 164,931.00 |
| Jun 30, 2025 | 164,931.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 4.46 Mn |
| Sep 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | 4.72 Mn |
| Jun 30, 2024 | 4.72 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Sep 30, 2023 | 4.88 Mn |
| Sep 30, 2023 | 4.88 Mn |